The First Hospital Affiliated to Zhejiang University School of Medicine

The First Hospital Affiliated to Zhejiang University School of Medicine: A National Treasure and Medical Exemplar—Forging a Life and Health Bastion that is “Domestically Leading and Globally Renowned”

I. Hospital Profile

The First Hospital Affiliated to Zhejiang University School of Medicine is a Grade A tertiary general hospital directly under the National Health Commission, integrating medical treatment, teaching, research, prevention, healthcare, and rehabilitation. Affiliated with Zhejiang University School of Medicine, it serves as the “pioneer” and “national team” within Zhejiang Province's healthcare system. Founded in 1947 as the “Affiliated Hospital of Zhejiang University School of Medicine,” the institution has evolved over more than 70 years into one of China's largest and most comprehensive hospitals.

Currently, The First Hospital Affiliated to Zhejiang University School of Medicine operates four major campuses—Zhijiang, Qingchun, Zijingang, and Chengzhan (covering a total area exceeding 800 mu)—with over 6,000 open beds. It handles more than 8 million outpatient and emergency visits annually and performs over 300,000 surgeries per year. In the 2023 Fudan University China Hospital Rankings, it ranked 14th nationally and has maintained a top-three position in East China for 15 consecutive years. In the 2023 China Hospital STEM (Science, Technology, Engineering, and Medicine) Metrics, 10 disciplines ranked among the national top 10, with 7 disciplines—including Infectious Diseases, Cardiovascular Medicine, and General Surgery—ranking among the national top 5.

Guided by its motto of “rigorous, pragmatic, and meticulous,” the hospital remains dedicated to its three core missions: treating complex and critical illnesses, advancing cutting-edge medical technologies, and cultivating medical talent. It serves not only as Zhejiang Province's center for diagnosing and treating complex diseases but also shoulders national responsibilities in emergency response to major public health events—such as the 2020 Wuhan COVID-19 outbreak and the 2022 Shanghai pandemic relief efforts—earning recognition as a “pioneering force” among China's medical institutions.

II. Technological Advantages: Innovation-Driven Leadership at the Forefront of Global Healthcare

The First Hospital Affiliated to Zhejiang University School of Medicine leverages “technological innovation” as its engine, establishing unique technical barriers in fields such as organ transplantation, critical care medicine, infectious diseases, precision medicine, and minimally invasive surgery. Its expertise is characterized by “possessing what others lack and excelling where others exist,” with multiple technologies filling domestic gaps and reaching internationally leading standards:

• Organ Transplantation Technology: As one of China's earliest hospitals to perform organ transplants, it has completed over 15,000 liver transplants (accounting for 1/10 of the national total) and over 10,000 kidney transplants. Its techniques in living donor liver transplantation, split liver transplantation, and pediatric liver transplantation are nationally leading. In 2023, it performed the world's first “pig-to-monkey” xenotransplantation liver transplant, advancing breakthroughs in clinical xenotransplantation applications.

• Critical Care Medicine and Emergency Critical Care: The Intensive Care Unit (ICU) is equipped with over 50 units of the world's most advanced ECMO (Extracorporeal Membrane Oxygenation) devices, providing ECMO support for over 300 cases annually (with a survival rate exceeding 50%); It has established a “golden hour” treatment system for trauma, sepsis, ARDS (Acute Respiratory Distress Syndrome), cardiac arrest, and other critical conditions, achieving a 92% success rate in emergency critical care.

• Infectious Diseases and Public Health: As one of China's three National Centers for Infectious Disease Medicine, it spearheaded the development of the “COVID-19 Diagnosis and Treatment Protocol” and pioneered critical COVID-19 treatment technologies, including prone position ventilation and artificial liver support systems. It maintains the world's largest database on hepatitis B-related hepatocellular carcinoma, achieving a clinical functional cure rate of 30% for hepatitis B (compared to the international average of 15%).

• Minimally Invasive and Precision Surgery: Established the “Da Vinci Surgical Robot Training Center,” completing over 30,000 robotic surgeries (covering urology, general surgery, thoracic surgery, etc.), with a 99% success rate for complex procedures like robot-assisted radical prostatectomy and gastrectomy. Pioneered precision surgeries using fluorescence-guided laparoscopy and 3D-printed personalized surgical guides, reducing trauma by 40%.

• Smart Healthcare and Digital Health: Established the “Zhejiang First Hospital Internet Hospital,” providing one-stop services including online consultations, appointment scheduling, and medication delivery, serving over 2 million patient visits annually. AI-assisted diagnostic systems (e.g., intelligent lung nodule detection, mammography screening for breast cancer) achieve over 97% accuracy, processing over 1 million screenings annually.

III. Leading Specialties: Powerhouse Clusters Addressing Lifecycle Needs

The hospital hosts one National Clinical Medical Research Center (Infectious Diseases) and eight National Key Clinical Specialties (Infectious Diseases, Cardiovascular Medicine, General Surgery, Hematology, Emergency Medicine, Nephrology, Clinical Pharmacy, Nursing), alongside over 20 provincial-level key medical disciplines. This forms a framework where “key specialties lead while subspecialties pursue precision development”:

1. Department of Infectious Diseases (National Clinical Medical Center)

The pinnacle of China's infectious disease field, annually treating over 50,000 complex infection cases. It maintains internationally leading capabilities in treating hepatitis B, hepatitis C, HIV/AIDS, fungal infections, and emerging/emergency infectious diseases (e.g., COVID-19, Ebola). Signature techniques include:

• Functional cure for hepatitis B (combining interferon, nucleoside analogues, and immune modulation);

• Artificial liver support system (DPMAS + plasma exchange) for severe hepatitis;

• Rapid diagnosis of emerging infectious diseases (metagenomic sequencing-based pathogen detection with 4-hour turnaround).

2. Cardiovascular Center (National Key Specialty)

Performs over 20,000 cardiac interventional procedures annually (including coronary stenting, radiofrequency ablation for arrhythmias, and interventional treatments for structural heart disease). Achieves a 99.5% success rate for complex coronary interventions (left main lesions, chronic total occlusions). Cardiac and Great Vessel Surgery performs high-complexity procedures, including the “Sun procedure” for aortic dissection and minimally invasive valve replacement (transcatheter aortic valve implantation, TAVI), with a surgical mortality rate below 0.8%.

3. General Surgery (National Key Specialty)

Subspecialties include Hepatobiliary Pancreatic Surgery, Gastrointestinal Surgery, and Thyroid and Breast Surgery:

• Hepatobiliary and Pancreatic Surgery: Performs laparoscopic pancreaticoduodenectomy (LPD) and radical resection for hilar cholangiocarcinoma, ranking among the top three nationally in case volume and complexity;

• Gastrointestinal Surgery: Annual robotic-assisted radical resection for gastric/colorectal cancer exceeds 800 cases, with 5-year survival rates surpassing 65%;

• Thyroid and Breast Surgery: Performs minimally invasive thyroid cancer radical resection (scarless neck) and breast-conserving reconstruction for breast cancer, achieving 98% cosmetic satisfaction.

4. Hematology (National Key Specialty)

Home to China's largest hematopoietic stem cell transplantation center, performing over 1,000 transplants annually (including autologous, allogeneic, and umbilical cord blood transplants). Achieves an 85% complete remission rate for acute leukemia with a 5-year survival rate exceeding 60%. Offers CAR-T cell therapy for refractory leukemia and lymphoma with an efficacy rate surpassing 70% (compared to the international average of 50%).

5. Emergency Medicine (National Key Specialty)

Established four major emergency networks: “Chest Pain Center,” “Stroke Center,” “Trauma Center,” and “Critical Maternal Care Center”:

• Chest Pain Center: Average D2B (door-to-balloon time) of 35 minutes (international standard ≤90 minutes);

• Stroke Center: Average DNT (door-to-needle time) of 25 minutes (international standard ≤60 minutes);

• Trauma Center: 90% success rate in rescuing severely injured patients (international average 80%).

IV. Departmental Structure: Comprehensive Coverage to Meet Diverse Healthcare Needs

Beyond the aforementioned specialty departments, the hospital also offers internal medicine (including respiratory and critical care medicine, gastroenterology, endocrinology, etc.), surgery (including neurosurgery, cardiothoracic surgery, urology, etc.), Obstetrics and Gynecology, Pediatrics, Ophthalmology, Otolaryngology, Dentistry, Rehabilitation Medicine, Traditional Chinese Medicine, Dermatology, Infectious Diseases, and more than 50 other clinical departments. Additionally, 15 medical technology departments, including Radiology, Laboratory Center, Pathology, and Ultrasound Medicine, provide comprehensive health management spanning prevention, diagnosis, treatment, and rehabilitation.

The Radiology Department is equipped with 3.0T MRI, 256-slice spiral CT, and PET-MR (Positron Emission Tomography-Magnetic Resonance Imaging) systems, performing whole-body vascular imaging and functional MRI (fMRI) with diagnostic accuracy exceeding 98%. The Rehabilitation Medicine Department utilizes robot-assisted gait training and transcranial magnetic stimulation (TMS) equipment, providing rehabilitation therapy to over 150,000 patients annually. The Pathology Department, designated as a National Pathology Quality Control Center, processes over 500,000 pathological diagnoses yearly with a 99% accuracy rate for complex cases.

V. Medical Equipment: Cutting-Edge Devices Empowering Precision Diagnosis and Treatment

The hospital is equipped with over 800 million yuan worth of imported high-end medical devices, some being the world's first or among the first introduced in China, providing robust support for clinical precision diagnosis and treatment:

• Surgical Robots: Da Vinci Xi Surgical Robot (Urology, General Surgery, Thoracic Surgery) from Intuitive Surgical (USA); Shurui Single-Port Laparoscopic Robot (Gynecology, Pediatrics) from China;

• Imaging Diagnostics: Philips Ingenia 3.0T MRI (3.0 Tesla Magnetic Resonance Imaging), Siemens SOMATOM Force Dual-Source CT (256-slice), GE Discovery PET-MR (Positron Emission Tomography-Magnetic Resonance Imaging);

• Critical Care & Emergency: Germany's Maquet ECMO (Extracorporeal Membrane Oxygenation), USA's Medtronic Intra-aortic Balloon Pump (IABP), Sweden's Jieding Hyperbaric Oxygen Chamber (for carbon monoxide poisoning, brain injury, etc.);

• Radiotherapy and Interventional: Varian TrueBeam linear accelerator (CyberKnife), Siemens Artis Q biplane angiography system (DSA);

• Rehabilitation Equipment: Hocoma Lokomat lower limb rehabilitation robot, ReWalk exoskeleton robot (assisting paraplegic patients in standing and walking).

VI. International Patient Services: Global Standards, Building a Borderless Healthcare Pathway

As a key medical gateway for Zhejiang Province's international outreach, the hospital leverages the Belt and Road medical cooperation platform to establish an international patient service system characterized by “language accessibility, seamless processes, and compassionate care”:

• Multilingual Support: Offers translation services in 10 languages, including English, Japanese, Korean, French, and Arabic (including medical-specific translation). All International Medical Department staff hold international healthcare certifications (e.g., JCI training).

• Seamless Payment: Direct billing partnerships with over 50 international insurers, including UnitedHealthcare (US), Japan's Ministry of Health, Labour and Welfare (MHLW), and Allianz (Europe), covering outpatient, inpatient, and diagnostic expenses;

• Comprehensive Accompaniment: Dedicated one-on-one customer service throughout admission registration, examinations, and medication pickup. Privacy protection complies with HIPAA (Health Insurance Portability and Accountability Act) and EU GDPR standards;

• Remote Consultations: Established video consultation partnerships with global top-50 hospitals, including Mayo Clinic (USA), Royal Free Hospital (UK), and National University Hospital (Singapore), enabling direct expert consultations;

• Lifestyle Services: The International Medical Department features private rooms (including family rooms and VIP suites), Chinese and Western cuisine, and wireless internet. Partner hotels offer premium accommodations near scenic areas like West Lake and Qianjiang New City.

VII. International Patient Testimonials: Authentic Experiences Highlighting Medical Compassion

• Michael (U.S. patient with end-stage liver disease): “In the U.S., I was told I could only wait for a liver transplant, but the waiting list required two years. After arriving at The First Hospital Affiliated to Zhejiang University School of Medicine, doctors performed a split liver transplant, using one donor liver to save both me and another patient. My post-operative recovery exceeded expectations—I'm now back to work. Thank you to the Chinese doctors for this ‘miracle of life’!”

• Japanese patient Yuki (acute myocardial infarction): “After suffering a sudden heart attack, I was rushed to The First Hospital Affiliated to Zhejiang University School of Medicine. The emergency team completed ECG and interventional surgery preparations within 10 minutes, and the stent procedure was highly successful. My attending physician explained my condition in detail in Japanese. During rehabilitation, he even taught me Chinese cardiac rehabilitation exercises. Now my heart rate and blood pressure are both stable!”

• French patient Sophie (systemic lupus erythematosus): "My lupus caused multi-organ damage, and treatment in France was ineffective. The rheumatology and immunology team at The First Hospital Affiliated to Zhejiang University School of Medicine developed a personalized treatment plan combining biologics and Chinese herbal medicine. After three months, my indicators showed significant improvement. The hospital environment feels like a garden, and the nurses always patiently listen to my needs—it's so warm!"

VIII. Contact Information, Address, and Transportation Routes

Hospital Address:

• Qingchun Campus: No. 79 Qingchun Road, Shangcheng District, Hangzhou, Zhejiang Province (Main Campus, Comprehensive Medical Services)

• Zhijiang Campus: No. 366 Wutong Road, Xihu District, Hangzhou, Zhejiang Province (Premium Medical Services, International Medical Services)

• Zijin Port Campus: No. 866, Yuhangtang Road, Xihu District, Hangzhou, Zhejiang Province (Emerging Disciplines, Research Translation)

• Chengzhan Campus: No. 58, Chengzhan Road, Shangcheng District, Hangzhou, Zhejiang Province (Emergency Care, Rehabilitation, Chronic Disease Management)

Contact Numbers:

• Main Switchboard: 0571-87236114 (Qingchun Campus); 0571-89986666 (Zhijiang Campus)

• International Patient Service Hotline: 0571-87236114 ext. 8008 (English/Japanese)

• Appointment Registration: WeChat Official Account “The First Hospital Affiliated to Zhejiang University School of Medicine” (supports WeChat, Alipay, phone appointments), Zhejiang Government Services App, 114 Platform

Transportation Guide:

• Qingchun Campus:

• Subway: Line 2 to “Qingchun Square Station” (Exit D, 500m walk);

• Bus: “Qingchun Campus Station” (Routes 105, 106, 202, etc.);

• Driving: Underground parking garage (3 levels, 1500+ spaces; arrive early during peak hours).

• Zhijiang Campus:

• Subway: Line 6 to “Zhijiang Cultural Center Station” (Exit A, 1 km walk);

• Bus: “Zhijiang Campus Station” (Direct routes: 308, 318);

• By car: Ground-level parking lot (800+ spaces) and underground parking garage (1,200+ spaces) available on campus.

Summary

The First Hospital Affiliated to Zhejiang University School of Medicine upholds the mission of “Excellence in Medicine, Dedication to Life.” With its comprehensive capabilities, specialized expertise, and innovative services, it serves not only as the “guardian of health” for Zhejiang residents but also as a trusted “medical destination” for international patients. Moving forward, the hospital will advance smart healthcare and precision medicine initiatives while deepening international collaborations, contributing its unique strength to building a global health community.

Document dated 2025-09-12 17:50 Modify